S Hacein-Bey - JoVE Visualize

Showing results (21-30 of 26) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 26 results.

Journal De La Societe De Biologie|September 4, 2001

[T-cell-depleted HLA non-identical bone marrow transplantation in the child: prevention of graft-versus-host reaction by administration of donor T lymphocytes alloreactive against the recipient]M Cavazzana-Calvo, I André-Schmutz, S Hacein-Bey, et al.

Gene Therapy|May 4, 2012

Critical variables affecting clinical-grade production of the self-inactivating gamma-retroviral vector for the treatment of X-linked severe combined immunodeficiencyJ C M van der Loo, W P Swaney, E Grassman, et al.

Leukemia|April 30, 2011

Stem cell self-renewal: lessons from bone marrow, gut and iPS toward clinical applicationsF J T Staal, C Baum, C Cowan, et al.

Leukemia|May 28, 2011

Correction of murine Rag1 deficiency by self-inactivating lentiviral vector-mediated gene transferK Pike-Overzet, M Rodijk, Y-Y Ng, et al.

Science (New York, N.Y.)|October 18, 2003

LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1S Hacein-Bey-Abina, C Von Kalle, M Schmidt, et al.

Nature Medicine|January 25, 2022

Long-term safety and efficacy of lentiviral hematopoietic stem/progenitor cell gene therapy for Wiskott-Aldrich syndromeA Magnani, M Semeraro, F Adam, et al.

Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 26 results.

Journal De La Societe De Biologie|September 4, 2001

[T-cell-depleted HLA non-identical bone marrow transplantation in the child: prevention of graft-versus-host reaction by administration of donor T lymphocytes alloreactive against the recipient]M Cavazzana-Calvo, I André-Schmutz, S Hacein-Bey, et al.

Gene Therapy|May 4, 2012

Critical variables affecting clinical-grade production of the self-inactivating gamma-retroviral vector for the treatment of X-linked severe combined immunodeficiencyJ C M van der Loo, W P Swaney, E Grassman, et al.

Leukemia|April 30, 2011

Stem cell self-renewal: lessons from bone marrow, gut and iPS toward clinical applicationsF J T Staal, C Baum, C Cowan, et al.

Leukemia|May 28, 2011

Correction of murine Rag1 deficiency by self-inactivating lentiviral vector-mediated gene transferK Pike-Overzet, M Rodijk, Y-Y Ng, et al.

Science (New York, N.Y.)|October 18, 2003

LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1S Hacein-Bey-Abina, C Von Kalle, M Schmidt, et al.

Nature Medicine|January 25, 2022

Long-term safety and efficacy of lentiviral hematopoietic stem/progenitor cell gene therapy for Wiskott-Aldrich syndromeA Magnani, M Semeraro, F Adam, et al.

Pageof 3